$DBA
INVESCO DB AGRICULTURE FUND

2021 Form 10-K Financial Statement

#000156459022006807 Filed on February 25, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $313.9K $2.026M
YoY Change -84.51% -78.19%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.203M $4.003M
YoY Change 104.9% 1.68%
Operating Profit -$7.726M -$1.645M
YoY Change 369.77% -130.07%
Interest Expense $10.84K $9.022K
YoY Change 20.14% -75.73%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $161.8M $29.16M
YoY Change 455.04% -499.73%
Net Earnings / Revenue 51557.45% 1438.93%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $6.658M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $648.9M
YoY Change 86.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $408.6K
YoY Change 67.43%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $648.5M
YoY Change
Total Liabilities & Shareholders Equity $648.9M
YoY Change 86.44%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income $161.8M $29.16M
YoY Change 455.04% -499.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$214.6M -$265.0M
YoY Change -19.04% -285.24%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$207.9M -$271.5M
YoY Change -23.43% -302.18%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 207.9M 271.5M
YoY Change -23.43% -289.99%
NET CHANGE
Cash From Operating Activities -214.6M -265.0M
Cash From Investing Activities
Cash From Financing Activities 207.9M 271.5M
Net Change In Cash -6.658M 6.497M
YoY Change -202.49% 3913.07%
FREE CASH FLOW
Cash From Operating Activities -$214.6M -$265.0M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
6464955
CY2020Q4 us-gaap Cash
Cash
6658401
CY2020Q4 us-gaap Dividends Receivable
DividendsReceivable
5484
CY2020Q4 us-gaap Assets
Assets
648871993
CY2021Q4 dba Payable To Clearing Organizations
PayableToClearingOrganizations
11724005
CY2021Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.00070
CY2021Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2022-03-10
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1030473392
CY2021Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0122
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1030651855
CY2019 dba Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
11336
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
29312
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7294229
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
538270063
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
330367642
CY2021 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
207902421
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-7725748
CY2021 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
205879844
CY2021 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-36319903
CY2021 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
369736614
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
347795397
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1644585
CY2020 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-28778835
CY2020 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
59580445
CY2020 us-gaap Net Income Loss
NetIncomeLoss
29157025
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
494781661
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
89315901
CY2019 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
223607356
CY2019 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-134291455
CY2019 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5400580
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
648463433
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6658401
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6496517
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
161884
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
5468641
CY2019 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-42481477
CY2019 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
29718607
CY2019 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-146986264
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
347795397
CY2020 us-gaap Net Income Loss
NetIncomeLoss
29157025
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7294229
CY2020 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
653181102
CY2019 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
938196266
CY2020 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
591995753
CY2019 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1202731831
CY2020 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1276954604
CY2019 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1138675218
CY2020 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
1051257153
CY2019 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
1033470278
CY2020 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-1052233
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-6974031
CY2020 dba Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
1810
CY2019 dba Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
35880
CY2020 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
65727
CY2019 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
104282
CY2020 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
6401988
CY2019 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
1686490
CY2020 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-68501
CY2019 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
29704
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
163531
CY2019 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-138593
CY2020 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
1007
CY2019 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
217
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-265014494
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
143067633
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
5400580
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
420849850
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
89315901
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
149338839
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
223607356
CY2019 dba Increase Decrease In Payable For Amount Due To Custodian
IncreaseDecreaseInPayableForAmountDueToCustodian
-3213714
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
207902421
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
271511011
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1018200047
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">B.</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Accounting Estimates</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financial statements are issued</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
CY2019Q4 us-gaap Cash
Cash
161884
CY2020 us-gaap Interest Paid Net
InterestPaidNet
9022
CY2019 us-gaap Interest Paid Net
InterestPaidNet
37166
CY2006Q3 dba Number Of Series Of Trusts
NumberOfSeriesOfTrusts
7
CY2015Q1 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2021 dba Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
CY2021 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2021 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2021 us-gaap Distributed Earnings
DistributedEarnings
0
CY2020 us-gaap Distributed Earnings
DistributedEarnings
0
CY2021 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2021 dba Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
CY2021 dba Number Of Shares Redeemable Per Creation Unit
NumberOfSharesRedeemablePerCreationUnit
100000
CY2021 us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5 - Deposits with Commodity Broker and Custodian</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund defines cash as cash held by the Custodian. There were no cash equivalents held by the Fund as of December 31, 2021 and 2020.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the commodity futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements. </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption <span style="font-style:italic;">Due to custodian</span>.</p>
CY2020Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
707011311
CY2021 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.56
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.94
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.33
CY2019 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.26
CY2021 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0090
CY2021 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0092
CY2020 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0094
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.2232
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0260
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0070
CY2021 dba Return At Market Value
ReturnAtMarketValue
0.2237
CY2020 dba Return At Market Value
ReturnAtMarketValue
-0.0254
CY2019 dba Return At Market Value
ReturnAtMarketValue
-0.0076

Files In Submission

Name View Source Status
0001564590-22-006807-index-headers.html Edgar Link pending
0001564590-22-006807-index.html Edgar Link pending
0001564590-22-006807.txt Edgar Link pending
0001564590-22-006807-xbrl.zip Edgar Link pending
dba-10k_20211231.htm Edgar Link pending
dba-10k_20211231_htm.xml Edgar Link completed
dba-20211231.xsd Edgar Link pending
dba-20211231_cal.xml Edgar Link unprocessable
dba-20211231_def.xml Edgar Link unprocessable
dba-20211231_lab.xml Edgar Link unprocessable
dba-20211231_pre.xml Edgar Link unprocessable
dba-ex231_9.htm Edgar Link pending
dba-ex311_8.htm Edgar Link pending
dba-ex312_6.htm Edgar Link pending
dba-ex321_10.htm Edgar Link pending
dba-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gfkwntxnjz1x000001.jpg Edgar Link pending
gfkwntxnjz1x000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending